These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12692839)

  • 1. Tumour suppressor gene expression correlates with gastric cancer prognosis.
    Lee HS; Lee HK; Kim HS; Yang HK; Kim WH
    J Pathol; 2003 May; 200(1):39-46. PubMed ID: 12692839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Fhit, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype.
    Hara A; Yashima K; Yasugi A; Koda M; Kawaguchi K; Harada K; Andachi H; Shiota G; Ito H; Murawaki Y
    Oncol Rep; 2007 Sep; 18(3):553-9. PubMed ID: 17671701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
    Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
    Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor genes in lung cancer.
    Virmani AK; Gazdar AF
    Methods Mol Biol; 2003; 222():97-115. PubMed ID: 12710682
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
    Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
    Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
    J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
    Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
    Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
    Oncol Rep; 2004 May; 11(5):1011-5. PubMed ID: 15069540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FHIT gene in gastric cancer: association with tumour progression and prognosis.
    Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
    J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
    Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
    Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
    Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
    Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clinical features and outcomes of gastric cancers with microsatellite instability.
    Lee HS; Choi SI; Lee HK; Kim HS; Yang HK; Kang GH; Kim YI; Lee BL; Kim WH
    Mod Pathol; 2002 Jun; 15(6):632-40. PubMed ID: 12065777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.